Cathepsin S or MMP9 inhibitors can be employed to reinforce the BBB, and when combined with anti-VEGF therapy, may suppress pro-angiogenic activity, thereby blocking early steps of tumor cell invasion and colonization. Here, MMP9 is linked to neoplasm.